These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 14633609)

  • 1. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.
    Geisbert TW; Young HA; Jahrling PB; Davis KJ; Larsen T; Kagan E; Hensley LE
    Am J Pathol; 2003 Dec; 163(6):2371-82. PubMed ID: 14633609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.
    Geisbert TW; Hensley LE; Larsen T; Young HA; Reed DS; Geisbert JB; Scott DP; Kagan E; Jahrling PB; Davis KJ
    Am J Pathol; 2003 Dec; 163(6):2347-70. PubMed ID: 14633608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
    Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
    J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation.
    Yen JY; Garamszegi S; Geisbert JB; Rubins KH; Geisbert TW; Honko A; Xia Y; Connor JH; Hensley LE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S1043-52. PubMed ID: 21987740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation in nonhuman primates of vaccines against Ebola virus.
    Geisbert TW; Pushko P; Anderson K; Smith J; Davis KJ; Jahrling PB
    Emerg Infect Dis; 2002 May; 8(5):503-7. PubMed ID: 11996686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever.
    Rubins KH; Hensley LE; Wahl-Jensen V; Daddario DiCaprio KM; Young HA; Reed DS; Jahrling PB; Brown PO; Relman DA; Geisbert TW
    Genome Biol; 2007; 8(8):R174. PubMed ID: 17725815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.
    Geisbert TW; Young HA; Jahrling PB; Davis KJ; Kagan E; Hensley LE
    J Infect Dis; 2003 Dec; 188(11):1618-29. PubMed ID: 14639531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily.
    Hensley LE; Young HA; Jahrling PB; Geisbert TW
    Immunol Lett; 2002 Mar; 80(3):169-79. PubMed ID: 11803049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Transcriptional Changes within Liver, Adrenal Gland, and Lymphoid Tissues Significantly Contribute to Ebola Virus Pathogenesis in Cynomolgus Macaques.
    Jankeel A; Menicucci AR; Woolsey C; Fenton KA; Mendoza N; Versteeg K; Cross RW; Geisbert TW; Messaoudi I
    J Virol; 2020 May; 94(11):. PubMed ID: 32213610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.
    Strong JE; Wong G; Jones SE; Grolla A; Theriault S; Kobinger GP; Feldmann H
    Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17982-7. PubMed ID: 18981410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-encoded miRNAs in Ebola virus disease.
    Duy J; Honko AN; Altamura LA; Bixler SL; Wollen-Roberts S; Wauquier N; O'Hearn A; Mucker EM; Johnson JC; Shamblin JD; Zelko J; Botto MA; Bangura J; Coomber M; Pitt ML; Gonzalez JP; Schoepp RJ; Goff AJ; Minogue TD
    Sci Rep; 2018 Apr; 8(1):6480. PubMed ID: 29691416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies.
    Qiu X; Audet J; Wong G; Pillet S; Bello A; Cabral T; Strong JE; Plummer F; Corbett CR; Alimonti JB; Kobinger GP
    Sci Transl Med; 2012 Jun; 4(138):138ra81. PubMed ID: 22700957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. African swine fever virus infection of porcine aortic endothelial cells leads to inhibition of inflammatory responses, activation of the thrombotic state, and apoptosis.
    Vallée I; Tait SW; Powell PP
    J Virol; 2001 Nov; 75(21):10372-82. PubMed ID: 11581405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.
    Jahrling PB; Geisbert JB; Swearengen JR; Larsen T; Geisbert TW
    J Infect Dis; 2007 Nov; 196 Suppl 2():S400-3. PubMed ID: 17940976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.
    Geisbert TW; Hensley LE
    Expert Rev Mol Med; 2004 Sep; 6(20):1-24. PubMed ID: 15383160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primates.
    Hensley LE; Geisbert TW
    Thromb Haemost; 2005 Aug; 94(2):254-61. PubMed ID: 16113813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
    Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.
    Iampietro M; Younan P; Nishida A; Dutta M; Lubaki NM; Santos RI; Koup RA; Katze MG; Bukreyev A
    PLoS Pathog; 2017 May; 13(5):e1006397. PubMed ID: 28542576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola virus: unravelling pathogenesis to combat a deadly disease.
    Hoenen T; Groseth A; Falzarano D; Feldmann H
    Trends Mol Med; 2006 May; 12(5):206-15. PubMed ID: 16616875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p inhibitors can reduce the cytotoxicity of Ebola virus glycoprotein in vitro.
    Sheng M; Zhong Y; Chen Y; Du J; Ju X; Zhao C; Zhang G; Zhang L; Liu K; Yang N; Xie P; Li D; Zhang MQ; Jiang C
    Sci China Life Sci; 2014 Oct; 57(10):959-72. PubMed ID: 25218824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.